State Street Health Care SPDR (XLV) Sells Eli Lilly and J&J on Nov. 9
State Street Health Care Select Sector SPDR ETF (XLV) sold $320.2 million in assets on Nov. 9, reducing positions in all 60 holdings. Largest sales included Eli Lilly (LLY) at $53.1 million, Johnson & Johnson (JNJ) at $31.9 million, and AbbVie (ABBV) at $24.4 million. XLV manages $50.54 billion in assets with a 0.08% expense ratio.
How this was made
The 30-second read
Why it matters
The fund's sizable sell pressure may temporarily depress the prices of the affected stocks, but the impact is likely short‑lived as the ETF remains heavily weighted in these names.
Market read
The disclosed sell‑off provides fresh data on fund flows, useful for short‑term traders monitoring liquidity and sentiment in major healthcare stocks.
What to watch
Fund may be rotating into other healthcare sub‑segments or preparing for upcoming earnings releases.
Background
State Street Health Care Select Sector SPDR (XLV) reported a $320.2 M net sell across all holdings, with the largest trims in LLY, JNJ, and ABBV.
Ticker impact
XLV sold $53.1 M of Eli Lilly shares, 16.58% of the fund, indicating a sizable reduction.
likely pressure as the market prices in the fund's sell-off
The ETF's $53 M sell represents a notable reduction in demand for LLY shares.
XLV sold $31.9 M of Johnson & Johnson, 9.98% of the fund's holdings.
likely pressure as the fund reduces its stake
A $31 M sell by a major healthcare ETF can weigh on JNJ price briefly.
XLV sold $24.4 M of AbbVie shares, 7.61% of the fund.
likely pressure as the fund cuts exposure
The sell amount is sizable relative to the ETF's holdings.
XLV sold $17.2 M of Merck shares, 5.39% of the fund.
likely pressure as the fund trims its Merck position
A $17 M sell by a large healthcare ETF can affect MRK sentiment.
XLV sold $16.8 M of UnitedHealth Group, 5.24% of the fund.
likely pressure as the fund reduces its UNH exposure
The fund's $16 M sell is a notable reduction in demand for UNH.
Market effects
Shows a broad pullback in healthcare sector exposure by a major ETF, could signal sector‑wide sentiment shift.
U.S. market impact as XLV is a large U.S. healthcare ETF.
Limited to investors tracking U.S. healthcare equities.
Counterpoint
The sell could be a tactical rebalancing rather than a negative outlook on the stocks.
Key entities
- ETFState Street Health Care Select Sector SPDR ETF
XLV, a $50.5 B healthcare sector ETF.
